Pelosi lives in one of San Francisco’s poshest neighborhoods, which is about 2 miles from one of the most drug-infested ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Many counterfeit, substandard, unregistered and expired pharmaceutical products, including Analgin, controlled substances such as tramadol 225mg, amongst others were on Friday destroyed by the ...

As nicotine pouches proliferate the market — and teen mouths — state lawmakers considered expanding the definition of tobacco ...

The viral post sparked discussion among social media users, one saying: "welcome to the civilized world where health care is ...

Egg prices are on the decline, but a spring migration could upend that. Former FDA Scott Gottlieb has ideas on how to prevent ...

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are ...

Find insight on BioNTech, PharmAla Biotech, Dentalcorp Holding and more in the latest Market Talks covering the Health Care ...

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...